These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1015538)

  • 1. Results of BCG adjuvant immunotherapy for melanoma of the head and neck.
    Eilber FR; Townsend CM; Morton DL
    Am J Surg; 1976 Oct; 132(4):476-9. PubMed ID: 1015538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.
    Eilber FR; Morton DL; Holmes EC; Sparks FC; Ramming KP
    N Engl J Med; 1976 Jan; 294(5):237-40. PubMed ID: 1244548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma.
    Veronesi U; Adamus J; Aubert C; Bajetta E; Beretta G; Bonadonna G; Bufalino R; Cascinelli N; Cocconi G; Durand J; De Marsillac J; Ikonopisov RL; Kiss B; Lejeune F; MacKie R; Madej G; Mulder H; Mechl Z; Milton GW; Morabito A; Peter H; Priario J; Paul E; Rumke P; Sertoli R; Tomin R
    N Engl J Med; 1982 Oct; 307(15):913-6. PubMed ID: 7050717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results of a randomized trial of adjuvant immunotherapy in patients with malignant melanoma who have lymph node metastases.
    Morton DL; Eilber FR; Holmes EC; Ramming KP
    Aust N Z J Surg; 1978 Feb; 48(1):49-52. PubMed ID: 276348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regional control of head and neck melanoma with selective neck dissection.
    Geltzeiler M; Monroe M; Givi B; Vetto J; Andersen P; Gross N
    JAMA Otolaryngol Head Neck Surg; 2014 Nov; 140(11):1014-8. PubMed ID: 25275362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BCG immunotherapy as a systemic adjunct to surgery in malignant melanoma.
    Morton DL; Eilber FR; Holmes EC; Sparks FC; Ramming K
    Med Clin North Am; 1976 May; 60(3):431-9. PubMed ID: 1271888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant BCG immunotherapy for stage I and II malignant melanoma.
    Silver HK; Ibrahim EM; Evers JA; Thomas JW; Murray RN; Spinelli JJ
    Can Med Assoc J; 1983 Jun; 128(11):1291-5. PubMed ID: 6342739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of survival and disease control in stage I melanoma of the head and neck.
    Ames FC; Sugarbaker EV; Ballantyne AJ
    Am J Surg; 1976 Oct; 132(4):484-91. PubMed ID: 1015539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralymphatic and regional surgical adjuvant immunotherapy in high-risk melanoma of the extremities.
    Ariyan S; Kirkwood JM; Mitchell MS; Nordlund JJ; Lerner AB; Papac RJ
    Surgery; 1982 Sep; 92(3):459-63. PubMed ID: 7112396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of lymph nodes in head and neck melanoma: a retrospective study of 25 cases].
    Ricard AS; Majoufre-Lefebvre C; Delaunay M; Siberchicot F; Zwetyenga N
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):505-8. PubMed ID: 17900640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recurrence and survival after neck dissections in cutaneous head and neck melanoma.
    Andersen PS; Chakera AH; Thamsborg AK; Kølle SF; Schmidt G; Klyver H; Drzewiecki KT
    Dan Med J; 2014 Dec; 61(12):A4953. PubMed ID: 25441725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elective, therapeutic, and delayed lymph node dissection for malignant melanoma of the head and neck: analysis of 1444 patients from 1970 to 1998.
    Fisher SR
    Laryngoscope; 2002 Jan; 112(1):99-110. PubMed ID: 11802046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCG immunotherapy of malignant melanoma: summary of a seven-year experience.
    Morton DL; Eilber FR; Holmes EC; Hunt JS; Ketcham AS; Silverstein MJ; Sparks FC
    Ann Surg; 1974 Oct; 180(4):635-43. PubMed ID: 4412271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant immunotherapy with BCG in stage II malignant melanoma.
    Byrne MJ; Van Hazel G; Reynolds PM; Lemish WM; Holman CD
    J Surg Oncol; 1983 Jun; 23(2):114-6. PubMed ID: 6343725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent cutaneous melanoma of the head and neck.
    Zitsch RP; Roberts GD; Smith RB
    Otolaryngol Head Neck Surg; 1999 Mar; 120(3):391-3. PubMed ID: 10064644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective surgical management of cutaneous melanoma of the head and neck.
    Roses DF; Harris MN; Grunberger I; Gumport SL
    Ann Surg; 1980 Nov; 192(5):629-32. PubMed ID: 7436592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of low-dose technetium Tc 99m sulfur colloid to locate sentinel lymph nodes in melanoma of the head and neck: preliminary study.
    Rasgon BM
    Laryngoscope; 2001 Aug; 111(8):1366-72. PubMed ID: 11568570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recurrent malignant melanoma: effect of adjuvant immunotherapy on survival.
    McCulloch PB; Dent PB; Blajchman M; Muirhead WM; Price RA
    Can Med Assoc J; 1977 Jul; 117(1):33-6. PubMed ID: 861909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cutaneous malignant melanoma of the head and neck with intermediate tumor thickness: the role of elective lymph node dissection for clinical stage I].
    Wenzel S; Sagowski C; Neuber K; Kehrl W; Metternich FU
    Laryngorhinootologie; 2003 Jan; 82(1):19-24. PubMed ID: 12548460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG immunotherapy in patients with malignant melanoma.
    Karakousis CP; Douglass HO; Yeracaris PM; Holyoke ED
    Arch Surg; 1976 Jun; 111(6):716-8. PubMed ID: 776125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.